See The Difference

The difference is that CloSys provides a natural and safe closure using the patient's own deheparinized blood. It's the safety and certainty of manual compression and the convenience of rapid closure in one product: the CloSys HD.

See how the HD works

A New Generation of Vascular Closure

Second generation device designers listened carefully to the market's demands for quick, reliable, safer, easier to use, and less expensive closure systems. Eliminating intravascular components and biologically active foreign materials has made the devices safer. Most second generation devices are much easier to use than their predecessors. Prices are not noticeably lower at this time.

Only CloSys provides safe, natural closure in an easy-to-use product at a lower price.

News

  • C.J. Schweich,Jr., M.D. joins CloSys as medical director for the U.S. pivotal clinical trial.
  • FDA approved the CloSys Investigational Device Exemption application and clears the way for the US pivotal trial.
  • Drs Byron Simmons and Kendall Price (Central Regional Pathology Laboratories) join CloSys medical advisory board as hematopathology consultants.